Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

bioRxiv logoLink to bioRxiv
[Preprint]. 2023 Feb 3:2023.02.01.526630. [Version 1] doi: 10.1101/2023.02.01.526630

Construction of a searchable database for gene expression changes in spinal cord injury experiments

Eric C Rouchka 1,2,3,*, Carlos de Almeida 4,5, Randi B House 5,6, Jonah C Daneshmand 3, Julia H Chariker 2,7, Sujata Saraswat-Ohri 5,8, Cynthia Gomes 5,9, Morgan Sharp 5,8, Alice Shum-Siu 5,8, Greta M Cesarz 5, Jeffrey C Petruska 5,8,9, David SK Magnuson 4,5,8,9
PMCID: PMC9915599  PMID: 36778366

Abstract

Spinal cord injury (SCI) is a debilitating disease resulting in an estimated 18,000 new cases in the United States on an annual basis. Significant behavioral research on animal models has led to a large amount of data, some of which has been catalogued in the Open Data Commons for Spinal Cord Injury (ODC-SCI). More recently, high throughput sequencing experiments have been utilized to understand molecular mechanisms associated with SCI, with nearly 6,000 samples from over 90 studies available in the Sequence Read Archive. However, to date, no resource is available for efficiently mining high throughput sequencing data from SCI experiments. Therefore, we have developed a protocol for processing RNA-Seq samples from high-throughput sequencing experiments related to SCI resulting in both raw and normalized data that can be efficiently mined for comparisons across studies as well as homologous discovery across species. We have processed 1,196 publicly available RNA-seq samples from 50 bulk RNA-Seq studies across nine different species, resulting in an SQLite database that can be used by the SCI research community for further discovery. We provide both the database as well as a web-based front-end that can be used to query the database for genes of interest, differential gene expression, genes with high variance, and gene set enrichments.

Keywords: spinal cord injury, SCI, ODC-SCI, RNA-Seq, bulk RNA-Seq, SQLite, transcriptomics, differential gene expression

INTRODUCTION

Spinal Cord Injury (SCI).

Spinal cord injury (SCI) is a debilitating disease resulting in an estimated 18,000 new cases in the United States annually, with over 80% of the cases caused by auto accident, fall, gunshot wound, motorcycle accident, or diving [1–3]. Approximately 1.4 million Americans are living with SCI [4]. Over the last 30 years, significant strides have been made in understanding the systems-wide pathophysiology and behavioral components affected by SCI, including axon growth [5–10], compensatory sprouting [11–17], glial cell roles [18–22], gut dysbiosis [23–26], and the role exercise plays in recovery [27–36]. However, successful translation of potential therapies remains elusive [37]. To capture and understand the heterogeneity of SCI and recovery from injury, researchers created the Open Data Commons for Spinal Cord Injury (odc-sci.org) [38] in 2017 to provide a platform for sharing SCI-related data adhering to the FAIR principles of Findable, Accessible, Interoperable, and Resuable [39]. As of 9/28/2022, a total of 176 complex datasets from 95 labs had been uploaded to ODC-SCI, and the structured data dictionaries that accompany each data set allow the data to be easily accessible and interoperable. While ODC-SCI contains a vast amount of data, one component that it does not catalog is transcriptomic data associated with RNA-Seq studies, largely because this data is generally easily accessible in resources such as the Gene Expression Ominibus (GEO) [40] or the Sequence Read Archive (SRA) [41]. While data from SRA and GEO are accessible, they are not generally interoperable to the average researcher to perform meta-analysis comparisons across experiments.

High Throughput Datasets.

The expansion in the utilization of high-throughput methodologies such as next generation sequencing along with numerous behavioral studies has led to the public availability of sets of data across the genome-to-phenome spectrum. Efforts to make this data usable to the larger scientific community have pushed for the data to adhere to the principles of being findable, accessible, interoperable, and reusable, or FAIR compliant [39]. The issue of making this data available was first recognized in a formal manner with microarray experiments, leading to the creation of the Minimum Information About a Microarray Experiment (MIAME) [42]. The MIAME standards led to guidelines for submission of high-throughput datasets to publicly available repositories such as the Gene Expression Omnibus (GEO) [40], The Sequence Read Archive (SRA) [41], ArrayExpress [43], and the Database of Genotypes and Phenotypes (dbGAP) [44]. More specifically, for SCI research, standards were created for describing the minimal information about a spinal cord experiment (MIASCI) [45].

Since the first RNA-Seq dataset related to spinal cord injury was made available in 2013 [46], the number of high throughput sequencing SCI datasets (including RNA-Seq) has grown exponentially (Figure 1). More recently, efforts to make sequencing data interoperable has extended into disease-specific domains, with cancer leading the way through The Cancer Genome Atlas (TCGA) [47] and Genomics Data Commons (GDC) [48]. Other efforts have been made to do this at tissue and gene levels through the Gene Tissue Expression (GTEx) database [49]. However, these projects typically classify samples in a binary fashion, into healthy or diseased states. This excludes other potentially pertinent characteristics. In the case of SCI, these additional characteristics may include organism (e.g. rat, mouse, zebrafish), injury type (e.g. contusion, transection, sham), injury force (e.g. 60 kdyn, 200 kdyn, 25 g/cm), injury level (e.g. C5, 5th cervical segment, T10, 10th thoracic segment), tissue type (e.g. spinal cord tissue at epicenter, spinal cord tissue below injury, isolated astrocytes from injured spinal cord, dorsal root ganglion), and time since injury (e.g. 1 hour post-injury, 24 hours post-injury, 60 days post-injury). Given the shortcomings with the interoperability of SCI transcriptomic data, we have developed a pipeline for preparing publicly available datasets for comparison across studies as well as across model organisms, resulting in both an SQLite database for the raw data, as well as a web interface for integrative analysis across studies.

Figure 1: Growth in number of high-throughput sequencing and RNA-Seq projects related to “spinal cord injury” or SCI in SRA, by release year.

Figure 1:

METHODS

Data selection and preparation.

Samples were located within the Sequence Read Archive (SRA) [41] using the search term “Spinal Cord Injury” OR SCI. From these, a total of 90 potential studies of interest were identified (Supplemental Table 1). Three additional SRA records related to neuropathic pain (SRP173586), nerve injury (SRP13362), and central nervous system (CNS) injury (SRP094587) were manually added, as were additional samples from the identified SRA studies that were not automatically included, due to differences in the specific search terms. A total of 5,891 samples were identified from these 93 studies, falling into one of twelve categories. The number of samples is inflated, due to one single cell RNA-Seq (scRNA-seq) study (SRP239303) where each of the 3,687 cells sequenced is represented as its own sample. Those samples corresponding to an RNA-seq assay were manually reclassified to the most appropriate assay type as RNA-seq (bulk), scRNA-seq, ribosomal-associated RNA-seq (RAM-seq), and transplanted RNA-seq. A handful of assay types were not consistently labeled and were reclassified from RNA-seq to microRNA (miRNA-seq) or noncoding RNA-Seq (ncRNA-Seq). The final filtered data for each of these classifications is shown in Table 1. The 50 bulk RNA-seq studies (Table 2) were selected for further processing, representing 1,196 samples from nine different species, the majority being mouse, rat, frog, and human (Table 3). RNA-Seq samples were downloaded from SRA using the sratoolkit [50]:

Table 1:

Classification of samples identified.

Sequencing Type Number of Studies Number of Samples

Single cell RNA-Seq 15 4,062
RNA-Seq (bulk) 50 1,196
Amplicon 9 374
miRNA-Seq 6 118
Other 2 68
RAM-Seq 1 23
ncRNA-Seq 3 22
Transplanted cells 1 19
ChIP-Seq 1 4
RIP-Seq 1 4
ATAC-Seq 1 2
WGS 1 2
CLONE 1 1
Targeted capture 1 1
WXS 1 1

Table 2:

SRA RNA-Seq studies included. Species codes are listed in Table 3.

SRA Study ID Org GEO ID Study Title Pubmed

SRP255811 Am Preclinical molecular signatures of spinal cord functional restoration: optimizing the metamorphic axolotl (Ambystoma mexicanum) model in regenerative medicine
SRP255836 Am Identification of the molecular signatures and functional restoration of the spinal cord of metamorphic axolotl
SRP334274 Dr GSE182869 Next Generation Sequencing of zebrafish intraspinal serotonergic neurons in the injury segment and distal segments after spinal cord injury (zebrafish) 34876587
SRP259365 Hs GSE149664 Generation of induced motor neurons (iMNs) from human fibroblasts facilitates locomotor recovery after spinal cord injury 32571478
SRP265127 Hs GSE151371 Blood biomarkers for spinal cord injury (human) 33512429
SRP220569 Md Identification of regenerative processes in neonatal spinal cord injury in the opossum (Monodelphis domestica)
DRP003667 Mm Genome-wide expression analysis of reactive astrocytes in the injured spinal cord at 7 days after spinal cord injury, host astrocytes in the naive spinal cord, and transplanted astrocytes in the naive spinal cord at 7 days after being transplanted
DRP003669 Mm Genome-wide expression analysis in the naive spinal cord and the injured spinal cord at 14 day after spinal cord injury
SRP019916 Mm GSE45376 RNA-Seq characterization of spinal cord injury transcriptome in acute/subacute phases: a resource for understanding the pathology at the systems level 23951329
SRP049253 Mm GSE62698 Spinal cord injury (RNA sequencing data) 25385836
SRP067494 Mm GSE76097 In vivo analysis of astrocyte ribosome-associated mRNA after traumatic spinal cord injury 27027288
SRP079387 Mm GSE84737 Macrophage transcriptional profile identifies lipid catabolic pathways that can be therapeutically targeted after spinal cord injury 28130359
SRP094587 Mm GSE90908 Characterization of meningeal type 2 innate lymphocytes and their response to CNS injury 27994070
SRP097644 Mm GSE93976 In vivo analysis of injury sites presenting full or attenuated pericyte-derived scarring after spinal cord injury (SCI) 29502968
SRP101665 Mm GSE96054 Time-course analysis of astrocyte-specific RNA-seq in two severities of spinal cord injury 27716282
SRP101667 Mm GSE96055 Time-course analysis of microglia-specific RNA-seq in two severities of spinal cord injury 28420963
SRP133622 Mm GSE111216 Mouse transcriptomics reveals extracellular matrix organization as a major pathway involved in inflammatory and neuropathic pain 30763288
SRP142367 Mm GSE113566 Microglia and macrophages promote corralling, wound compaction and recovery in spinal cord injury via Plexin-B2 32112058
SRP173586 Mm GSE123919 Translational profiling of dorsal root ganglia and spinal cord in a mouse model of neuropathic pain 30906902
SRP179750 Mm GSE125176 Cellular response of mesenchymal stem cells transplanted into spinal cord injury (house mouse) 30944028
SRP201114 Mm GSE132552 Transcriptional changes after spinal cord injury: recruitment of afferents distal to the site of injury
SRP226573 Mm GSE130227 Syngeneic, in contrast to allogeneic, mesenchymal stem cells have superior therapeutic potential following spinal cord injury
SRP259320 Mm GSE149646 Ascending dorsal column sensory neurons respond to spinal cord injury and downregulate genes related to lipid metabolism (house mouse) 33431991
SRP269775 Mm GSE153720 Systematic analysis of purified astrocytes after spinal cord injury unveils lncRNA Zeb2os as a novel molecular target for astrogliosis [RNA-Seq] (house mouse) 33535036
SRP313384 Mm GSE171441 Gsx1 Promotes Locomotor Functional Recovery After Spinal Cord Injury 33895323 34343529
SRP325651 Mm GSE178930 Next Generation Sequencing Facilitates Quantitative Analysis of Wild and spinal cord injury mice (house mouse)
SRP101364 Pm GSE95686 RNA-Seq analysis after spinal cord injury in lamprey reveals distinct transcriptional responses during functional recovery in spinal cord and brain 29335507
SRP049326 Rn GSE62760 T Cell Deficiency in Spinal Cord Injury: Altered Locomotor Recovery and Whole-Genome Transcriptional Analysis 26546062
SRP073355 Rn Transcriptome of Sprague-Dawley Rats -- spinal cord contusion
SRP096190 Rn GSE93249 RNA-Seq analysis of coding and long non-coding RNAs in the sub-chronic and chronic stages of spinal cord injury 28106101
SRP131816 Rn GSE109902 Transcriptional screen in the target region of sprouting hindlimb corticospinal fibers after thoracic spinal cord injury in rats (Norway rat)
SRP149309 Rn GSE115067 Integrated systems analysis reveals conserved gene networks underlying response to spinal cord injury (Norway rat) 30277459
SRP166392 Rn Following 6 days differentiation of neural stem cells in vitro
SRP176640 Rn GSE124819 Activity-induced changes in the liver transcriptome after chronic spinal cord injury 31197156 32226812
SRP179652 Rn GSE125134 Analysis of possible mechanisms behind functional recovery following neural progenitor cell transplantation into spinal cord injury. (Norway rat) 31031190
SRP181953 Rn GSE125630 Transcriptome of dorsal root ganglia caudal to a spinal cord injury with modulated behavioral activity 31175296 32226812
SRP192162 Rn GSE129694 Transcriptional changes in soleus muscle for rats exposed to different activities after contusion injury to the spinal cord and transcriptional changes in soleus muscle with complete spinal cord transection injury 32226812
SRP202013 Rn GSE133093 Brainstem control of transcription after spinal cord injury (SCI) 31803022
SRP213314 Rn Transcriptomic analysis of knockdown of ?-synuclein after T3 spinal cord injury in rats
SRP216808 Rn GSE135080 Novel drug-like RAR-Beta agonist induces BRCA1 to prevent neuropathic pain (Norway rat) 31726373
SRP224959 Rn GSE138637 Genome wide analysis of thoracic spinal cord at 5 days after T9 hemisection injury.
SRP273616 Rn Ketogenic diet-mediated steroid metabolism reprogramming improves the immune microenvironment and myelin growth of spinal cord injury rats through gene analysis and co-expression network analysis
SRP275629 Rn GSE155610 Transcriptome of Subcortical White Matter and Spinal Cord After Spinal Injury and Cortical Stimulation 34267212
SRP279076 Rn GSE156999 Circular RNAs expression profiles and potential key molecules incompletely transected spinal cord injury
SRP311591 Rn Sequencing for spinal cord injury
SRP082501 Ts Pool of tissues of Trachemys scripta elegans
DRP006873 Xl RNA-seq analysis after spinal cord injury in Xenopus laevis
SRP222957 Xl GSE137844 Comparative Gene Expression Profiling between Xenopus Optic Nerve and Spinal Cord Injury to Identify Genes Involved in Successful Regeneration of Vertebrate CNS Axons 32758133 34979916
SRP300206 Xl GSE164204 Cellular response to spinal cord injury in regenerative and non-regenerative stages in Xenopus laevis 33526076
SRP302901 Xl GSE165343 High expression profiling analysis of the early response to spinal cord injury identified a key role for mTORC1 signaling 34686684

Table 3:

Samples by species.

Species name Common name Species Code Number of RNA-Seq samples

Mus musculus House mouse Mm 569
Rattus norvegicus Norway rat Rn 297
Xenopus laevis African clawed frog Xl 176
Homo sapiens Human Hs 65
Mondelphis domestica Gray short-tailed opossum Md 42
Petromyzon marinus Sea lamprey Dm 22
Danio rerio Zebrafish Dr 11
Ambystoma mexicanum Axolotl Am 8
Trachemys scripta elegans Red-eared slider turtle Ts 6
fasterq-dump –skip-technical –x –p –split-3 <SRR RUN NUMBER> 

Eleven rat samples were omitted (SRR13562711-SRR13562722) due to issues with obtaining the samples with sratoolkit.

Samples were then processed for quality assurance and quality control (QA/QC) using fastQC [51].

Sequencing reads were aligned to the respective reference genomes guided by known transcriptomes (Table 4) using STAR [52]. Raw read counts were determined using the featureCounts R package [53]. Counts were extracted using three separate stranded settings, including –s 0 (unstranded), –s 1 (forward stranded), and –s 2 (reverse stranded). This step was performed to infer the most likely strandedness of the original library construction kit. Strandedness was also calculated using the infer_experiment.py script from the RSeqC package [54]. The resulting feature counts were reformatted to the same format of htSeqCount [55] using a custom script. The count information was then parsed to create a tab-delimited file of raw gene counts and TPM (transcripts per million) normalized counts [56]. Since TPM normalizes to both the library size and the transcript size, we utilized the R GenomicFeatures package [57] to determine gene lengths. The exception to this was the axolotl data, where a known transcriptome description is not currently available. In this case, those samples were constructed into de novo transcriptomes using Trinity [58].

Table 4:

Reference genomes and gene description files used.

Organism Reference Genome (Accession) GTF

Mus musculus GRCm38.p6 (mm10) Ensembl v101 (Mus_musculus.GRCm38.101.gtf)
Rattus norvegicus Rnor_6.0 (rn6) Ensembl v101 (Rattus_norvegicus.Rnor_6.0.101.gtf)
Xenopus laevis Xenla10.1 Genbank (GCF_017654675.1_Xenopus_laevis_v10.1_genomic.gtf)
Homo sapiens GRC38 (hg38) (GRC38.d1.vd1.fa) Gencode v22 (gencode.v22.annotation.gtf)
Mondelphis domestica ASM229v1 Ensembl v104 (Monodelphis_domestica.ASM29v1.104.gtf)
Petromyzon marinus kPetMar1 (GCF_010993605.1) Genbank (GCF_0100993605.1_kPetMar1.pri_genomic.gtf)
Danio rerio GRCz11 Ensembl v105 (Danio_rerio_GRCz11.105.chr.gtf)
Trachemys scripta elegans CAS_Tse_1.0 (GCF_013100865.1) Genbank (GCF_013100865.1_CAS_Tse_1.0_genomic.gtf)
Ambystoma mexicanum AmbMex60DD (GCA_002915635.3) (Transcriptome constructed from Trinity)

SQLite database construction.

Tab-delimited files representing data for ten SQLite tables were constructed, and then parsed into the SQLite database. Each table was connected to other tables via foreign keys, including the organism, gene identifier, SRA study identifier, and SRA sample identifier.

Data exploration.

When a data exploration study is chosen, the samples of interest are filtered by species using the raw sequencing reads determined by featureCounts. If samples from at least one of the groups mouse and human; mouse and rat; human and rat; or mouse, human, and rat are selected, then the genes are filtered for homologous genes across species using the NCBI Homologene identifiers [59]. Differential gene expression is calculated for the samples within each species individually, as well as for homologous genes across species using DESeq2 [60]. The resulting data is sorted by q-value (Storey’s FDR correction) from smallest to largest and parsed for up-regulated genes (those with a positive logFC) and down-regulated genes (those with a negative logFC). Heatmaps for the top 250 differentially expressed and top 250 variance genes are constructed, using a gene-wise z-score. Enriched GeneOntology Biological Processes [61] and KEGG pathways [62] are determined using ClusterProfiler [63].

RESULTS

RNA-Seq data.

A total of 1,196 samples from 50 bulk RNA-Seq studies were processed for inclusion in the SQLite database, with the majority originating from either spinal cord or dorsal root ganglion tissue (Figure 2). The injury site for these studies was varied, with the most common location thoracic, in particular between thoracic vertebrae 8 (T8) and T10 (Supplemental Figure S1). The time since injury was varied, with the majority occurring within the first two weeks, although a number of studies extended the time, all the way up to 24 weeks (Supplemental Figure S2). Over 30 unique injury types are represented (Supplemental Figure S3) with the most frequent being complete transection, contusion, and various controls, including sham and laminectomy. In many cases, the exact control type could not be extracted from the GEO entry and any associated publication and is therefore listed as uninjured or control.

Figure 2: Tissue types studied in filtered RNA-Seq experiments.

Figure 2:

Shown are (A) the tissue types for all samples; (B) tissue types for rat experiments; and (C) tissue types for mouse experiments.

SQLite database.

After the studies and their corresponding samples were processed, the resulting information was structured into an SQLite relational database consisting of 10 tables, as shown in the entity-relationship (ER) diagram in Figure 3. The total database size is just under 2.5 Gb.

Figure 3: Entity-relationship (ER) model for the SQLite database.

Figure 3:

Web front-end.

Utilization of the SQLite database was performed using a web-based application for querying the data. Presented on the web page is information about the constructed database (Figure 4), links and summaries for included studies (Supplemental Figure S4), downloadable files (Supplemental Figure S5), and database exploration (Figure 5).

Figure 4: SCI-GEE summary of SQLite database.

Figure 4:

Shown is the web entry point into SCI-GEE with a summary of the number of data points in the database.

Figure 5: Data exploration page.

Figure 5:

SCI-GEE users are presented with choices for species of interest, tissues of interest, injury of interest, and injury site of interest.

Data exploration.

The user begins a data exploration by first selecting the organisms, tissues, injury types, injury locations, and specific genes of interest. They are then presented with the resulting sample groups that can be selected for a pairwise analysis (Supplemental Figure S6). Once the differential expression analysis is complete, the user is returned a set of results, including the top 25 up- and down-regulated genes (Supplemental Figure S7), heatmaps for the top 250 differentially expressed genes (Supplemental Figure S8) and genes with the highest variance, PCA plot, volcano plot, heatmap for genes of interest, and GO:BP and KEGG pathway enriched categories.

DISCUSSION

Case Usage Studies.

Demonstration of the utility of SCI-GEE was performed with two usage studies in mouse and rat: 1) analysis of dorsal root ganglion (DRG) in spinal cord injured vs. uninjured samples; and 2) spinal cord tissue in spinal cord injured vs. uninjured samples. Mouse and rat were selected since they have the highest representation in the database. For both studies, results were available for three groups, including mouse and rat homologs; mouse genes only; and rat genes only. In the case of mouse and rat homologs, a total of 16,529 genes were compared based on shared homologene IDs [59], while the mouse samples were compared using 55,487 genes (including both protein coding and noncoding genes), and 32,883 rat genes were utilized for that comparison. While the data analyzed in SCI-GEE is available for download and utilization in other analytical workflows of interest, the results presented here are fully contained within the website functionality. For both tissue sets, the control and injured samples separated as illustrated by the PCA plots for DRG (Figure 6A) and spinal cord (Figure 6B), although a high degree of variance was found in the injured samples due to variability in other experimental factors, including injury type, severity, and time since injury.

Figure 6: PCA analysis based on gene expression.

Figure 6:

Shown are (A) PCA plot for DRG samples and (B) PCA plot for spinal cord tissues. Control samples are shown in orange and injured samples are shown in blue.

DRG tissue analysis.

For the DRG tissue dataset, two groups were created across mouse and rat: control samples (including both naïve and sham models) and spinal cord injured samples (Supplemental Table S2). The spinal cord injuries were from a variety of models, including hemisection, transection, and contusion. One of the meta-analysis capabilities of SCI-GEE is the ability to perform cross-species analysis across human, mouse, and rat gene expression by looking at the expression of common homologs across species. In these usage cases, shared homologene IDs across mouse and rat were examined. The top 25 up-regulated genes are shown in Supplemental Table S3, while the top 25 down-regulated genes are shown in Supplemental Table S4. Included in the up-regulated genes in the DRG for the mouse and rat meta-analysis are GADD45A, which is involved in cell cycle and neuronal cell death [64] and may act in a neuroprotective fashion [65–67]; GPR151 which is involved in neuropathic pain, and may promote axon regeneration [68, 69]; FLRT3 which promotes neurite outgrowth [70–72], CRLF1 which forms complexes with neurotrophic factors to promote survival of neuronal cells [73], and the neuropeptide GAL [74, 75]. At the top of the down-regulated genes are two leucine zipper proteins (FOSB and FOS), two zinc fingers (EGR1 and ZFP36), and CYR61. These all play roles in regulating cell proliferation and apoptosis, indicating that regulatory machinery is turned off in response to spinal cord injury. In the DRG for mouse only, the top 25 up-regulated genes are shown in Supplemental Table S5, and the top 25 down-regulated are shown in Supplemental Table S6. At the top of the up-regulated genes are GADD45A, FST, GPR151, IGFN1, and TES. The up-regulation of FST (follistatin) and TES (testin LIM domain protein) may be indicative of sex-specific differences in the makeup of the mouse samples, while GPR151 is known to modulate neuropathic pain [76, 77] and IGFN1 is involved in synapse assembly [78]. The top mouse down-regulated genes are similar to those found for mouse and rat homologs. The top 25 up-regulated genes in DRG for the rat only are shown in Supplemental Table S7, and the top 25 down-regulated genes are shown in Supplemental Table S8. Among the up-regulated genes are several members of the Hox gene family (Hoxc11, Hoxd10, and Hoxd11), which are important for motor neuron patterning [79–82], as well as peripheral myelin protein 2 (Pmp2). The down-regulated genes include Usp5 which modulates neuropathic and inflammatory pain [83], Tuba1a which is necessary for central nervous system development and regeneration [84], Csf1r which promotes microglial proliferation [85, 86], and Slc39a6 which is found in reactive astrocytes [87]. For each of the comparisons (both, mouse and rat, respectively), volcano plots were generated to show the overall pattern of expression, including the fold-change across the x-axis and the q-value significance across the y-axis (Figures 7A–C), which illustrates a relative even distribution of the data. Heatmaps were generated showing the top differentially expressed genes (Figures 8A–C), with the genes listed across the rows, and the samples across the columns.

Figure 7: Volcano plots shown for DRG samples.

Figure 7:

Shown are (A) meta-analysis of mouse and rat homologs combined, (B) mouse genes, and (C) rat genes.

Figure 8: Heatmaps for top differentially expressed genes in DRG injury vs. control comparison for (A) meta-analysis of mouse and rat homologs; (B) mouse samples; and (C) rat samples.

Figure 8:

DRG enrichment analysis.

Differentially expressed genes from the mouse and rat comparisons were used as input into ClusterProfiler [63] for analysis of enriched GeneOntology Biological Processes (GO:BP) [61] and KEGG Metabolic Pathways [62]. The top 20 GO:BP enrichments are shown in Figures 9A and 9B for mouse and rat respectively, while the top 20 KEGG enrichments are shown in Figures 10A and 10B. For the mouse differentially expressed genes, several of the top GO:BP annotations are associated with nervous system development, indicating responses for regeneration and collateral sprouting, including synapse organization, regulation of neurogenesis, axonogenesis, epithelial tube morphogenesis, and dendrite development. Others are associated with muscular development, including muscle tissue development, muscle cell differentiation, and striated muscle cell differentiation. A third cluster is related to cell signaling and adhesion, including cell-substrate adhesion, positive regulation of cell adhesion, regulation of metal ion transport, calcium ion transport, and cell junction assembly. Results are similar for the rat, including synaptic vesicle cycle, vesicle-mediated transport in synapse, axonogenesis, regulation of neurotransmitter levels, sensory perception of pain, neurotransmitter transport, neurotransmitter secretion, signal release from synapse, regulation of membrane potential, potassium ion transport, positive regulation of ion transport, protein localization to cell junction, and synaptic vesicle exocytosis. The KEGG pathway enrichment results are a little more difficult to parse, but include pathways of neurodegeneration, axon guidance and synaptic vesicle cycle, along with a number of seemingly unrelated pathways, many of which are tied to proinflammatory responses.

Figure 9: Top 20 GO:BP enrichments from clusterProfiler for DRG injury vs. control comparison for (A) mouse samples and (B) rat samples.

Figure 9:

Figure 10: Top 20 KEGG metabolic pathway enrichments from clusterProfiler for DRG injury vs. control comparison for (A) mouse samples and (B) rat samples.

Figure 10:

Spinal cord tissue analysis.

In the case of the spinal cord tissues, two groups were created across mouse and rat: control samples (including both naïve and sham models) and spinal cord injured samples (Supplemental Table S9). The spinal cord injuries were from a variety of models, including hemisection, transection, hemicontusion and contusion. Among the top up-regulated differentially expressed genes for the meta-analysis across mouse and rat homologs (Supplemental Table S10) are SIGLEC1 (CD169) which signals an increase in metallophilic macrophages and an increased immune response [88], GPNMB, a glioma-associated glycoprotein [89], MPEG1, a macrophage/microglia marker gene [90, 91], CCL13 which is produced from M2 macrophages [92], and CD68, a marker for phagocytic microglia [93]. Down-regulated genes (Supplemental Table S11) include HMGCS1, HMGCR MSMO1 and IDI1 which are involved in cholesterol metabolism, and whose down-regulation may prevent demyelination [94, 95]. The mouse only study shows similar results to the mouse and rat homologs, with Gpnmb, Ccl2, Bst2, Lyz2, and Trem2 among the top up-regulated genes (Supplemental Table S12). Ccl2 is a cytokine functioning in inflammation and pain following spinal cord injury [96] while Bst2 is a neuroinflammation biomarker [97]. Lyz2 is expressed in reactive microglia and macrophages [98], and Trem2 elicits a proinflammatory response in microglia [99]. Down-regulated genes include Cltrn, Aldob, Rapgef5, Mep1a, and Slc22a12 (Supplemental Table S13). Aldob has a role in glycolysis and glucogenesis [100] while Rapgef5 is involved in signal transduction with the Ras pathway [101]. Up-regulated genes for the rat-only spinal cord tissue includes Siglec1, Lilrb3, Gpnmb, Clec7a, and Mmp12 (Supplemental Table S14), similar to the results for the mouse and rat homologs. Ablation of Lilrb3 has been shown to promote neurite outgrowth [102], while Clec7a is a marker of actively proliferating microglia [103] and Mmp12 is involved in myelination. The top down-regulated rat genes include a number of genes with unknown function (Supplemental Table S15). Among those that have associated functions are Hmgcr, Mff, and Msmo1. As previously mentioned, Hmgcr and Msmo1 function in cholesterol metabolism, while Mff is associated with lengthening neuron life [104]. Volcano plots and heatmaps are provided in Figures 11A–B and Figures 12A–B, respectively.

Figure 11: Volcano plots shown for spinal cord samples.

Figure 11:

Shown are (A) meta-analysis of mouse and rat homologs, (B) mouse genes, and (C) rat genes.

Figure 12: Heatmaps for top differentially expressed genes in spinal cord injury vs. control comparison for (A) meta-analysis of mouse and rat homologs; (B) mouse samples; and (C) rat samples.

Figure 12:

Spinal cord enrichment analysis.

Among the top 20 GO:BP enrichments (Figures 13A–B) are a number of proinflammatory annotations, including negative regulation of immune system process, regulation of inflammatory response, leukocyte migration, leukocyte cell-cell adhesion, cytokine-mediated signalling pathway, leukocyte proliferation, regulation of T cell activation, regulation of leukocyte migration, and myeloid leukocyte activation. Enriched KEGG metabolic pathways (Figures 14A–B) include a number of signaling pathways (NF-kappa B signaling pathway, TNF signaling pathway, MAPK signaling pathway, B cell receptor signaling pathway, NOD-like receptor signaling pathway, Toll-like receptor signaling pathway, cytoking-cytokine receptor interaction, and Hippo signaling pathway, indicating that spinal cord injury leads to a number of signaling cascades in the spinal cord itself, consistent with previous findings [105–109].

Figure 13: Top 20 GO:BP enrichments from clusterProfiler for spinal cord injury vs. control comparison for (A) mouse samples and (B) rat samples.

Figure 13:

Figure 14: Top 20 KEGG metabolic pathway enrichments from clusterProfiler for spinal cord injury vs. control comparison for (A) mouse samples and (B) rat samples.

Figure 14:

Single cell transcriptomics.

More recent transcriptome work in the SCI field has included studies utilizing single cell RNA-Seq (scRNA-Seq) [98, 110–116], including a recent atlas of spinal cord injury in mice [114]. Due to the complexities of scRNA-Seq data, including cell typing and the disparity between limited sample numbers and large numbers of cells per sample, as well as a different modality for viewing scRNA-Seq data, we chose not to include that data at this time to focus on the more broadly available bulk RNA-Seq datasets. Over time, we anticipate that more scRNA-Seq datasets will be generated for SCI as costs come down. When that happens, we plan to develop a parallel method for integrating scRNA-Seq data. Such a resource would allow for more resolution at a single cell level, providing for an atlas of transcriptional changes for cells affected by SCI.

CONCLUSION

Our approach for preparing bulk RNA-seq data related to SCI allows for greater interoperability across datasets. This in turn enables for meta-analyses both within and across species. By providing the data in an SQLite format, potential users are able to either utilize our web interface for exploring the available data, or develop their own analysis pipelines the utilizes the prepared data. We hope this work will eventually be incorporated into ODC-SCI data types, allowing for even greater integration along the genome-to-phenome modalities.

Supplementary Material

Supplement 1
media-1.pdf (2.7MB, pdf)
Supplement 2
media-2.pdf (456.2KB, pdf)

ACKNOWLEDGEMENTS

Support provided by the Wings for Life Spinal Cord Research Foundation (grant WFL-US-17/20) and the National Institutes of Health (grant P20GM103436). The contents of this manuscript do not reflect the official views of the funding agencies.

AVAILABILITY

The SQLite database, flat files used to construct the database, and the web interface can be accessed at: http://162.215.210.70/~tracks/SCI-GEE/ .

REFERENCES

  • [1].National Spinal Cord Injury Statistics Center, “Spinal Cord Injury Model Systems 2021 Annual Report,” University of Alabama at Birmingham, https://www.nscisc.uab.edu/PublicDocuments/AR2021_public%20version.pdf , 2021 2021. [Google Scholar]
  • [2].National Spinal Cord Injury Statistics Center. “Frequently Asked Questions.” https://www.nscisc.uab.edu/Public_Pages/FAQ (accessed 9/28/2022, 2022).
  • [3].Jain N. B. et al. , “Traumatic spinal cord injury in the United States, 1993–2012,” Jama, vol. 313, no. 22, pp. 2236–2243, 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].Christopher and Dana Reeves Foundation. “Stats about paralysis.” https://www.christopherreeve.org/living-with-paralysis/stats-about-paralysis (accessed 9/28/2022, 2022).
  • [5].Anderson M. A. et al. , “Required growth facilitators propel axon regeneration across complete spinal cord injury,” Nature, vol. 561, no. 7723, pp. 396–400, 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [6].Bregman B. S., McAtee M., Dai H. N., and Kuhn P. L., “Neurotrophic factors increase axonal growth after spinal cord injury and transplantation in the adult rat,” Experimental neurology, vol. 148, no. 2, pp. 475–494, 1997. [DOI] [PubMed] [Google Scholar]
  • [7].Hellal F. et al. , “Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury,” Science, vol. 331, no. 6019, pp. 928–931, 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].Lu P., Jones L., Snyder E., and Tuszynski M., “Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury,” Experimental neurology, vol. 181, no. 2, pp. 115–129, 2003. [DOI] [PubMed] [Google Scholar]
  • [9].Lu P., Jones L., and Tuszynski M., “BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury,” Experimental neurology, vol. 191, no. 2, pp. 344–360, 2005. [DOI] [PubMed] [Google Scholar]
  • [10].Lu P. et al. , “Long-distance axonal growth from human induced pluripotent stem cells after spinal cord injury,” Neuron, vol. 83, no. 4, pp. 789–796, 2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11].Barritt A. et al. , “Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury,” Journal of Neuroscience, vol. 26, no. 42, pp. 10856–10867, 2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].Fouad K., Pedersen V., Schwab M. E., and Brösamle C., “Cervical sprouting of corticospinal fibers after thoracic spinal cord injury accompanies shifts in evoked motor responses,” Current Biology, vol. 11, no. 22, pp. 1766–1770, 2001. [DOI] [PubMed] [Google Scholar]
  • [13].Lee J. K. et al. , “Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice,” Neuron, vol. 66, no. 5, pp. 663–670, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [14].Maier I. C. and Schwab M. E., “Sprouting, regeneration and circuit formation in the injured spinal cord: factors and activity,” Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 361, no. 1473, pp. 1611–1634, 2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Raineteau O. and Schwab M. E., “Plasticity of motor systems after incomplete spinal cord injury,” Nature Reviews Neuroscience, vol. 2, no. 4, pp. 263–273, 2001. [DOI] [PubMed] [Google Scholar]
  • [16].Schwab M. E., “Repairing the injured spinal cord,” Science, vol. 295, no. 5557, pp. 1029–1031, 2002. [DOI] [PubMed] [Google Scholar]
  • [17].Weidner N., Ner A., Salimi N., and Tuszynski M. H., “Spontaneous corticospinal axonal plasticity and functional recovery after adult central nervous system injury,” Proceedings of the National Academy of Sciences, vol. 98, no. 6, pp. 3513–3518, 2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [18].Barnabé-Heider F. et al. , “Origin of new glial cells in intact and injured adult spinal cord,” Cell stem cell, vol. 7, no. 4, pp. 470–482, 2010. [DOI] [PubMed] [Google Scholar]
  • [19].Gaudet A. D. and Fonken L. K., “Glial cells shape pathology and repair after spinal cord injury,” Neurotherapeutics, vol. 15, no. 3, pp. 554–577, 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [20].Gwak Y. S., Kang J., Unabia G. C., and Hulsebosch C. E., “Spatial and temporal activation of spinal glial cells: role of gliopathy in central neuropathic pain following spinal cord injury in rats,” Experimental neurology, vol. 234, no. 2, pp. 362–372, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21].Kim D. et al. , “A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity,” Journal of Biological Chemistry, vol. 282, no. 20, pp. 14975–14983, 2007. [DOI] [PubMed] [Google Scholar]
  • [22].Liu X. Z. et al. , “Neuronal and glial apoptosis after traumatic spinal cord injury,” Journal of Neuroscience, vol. 17, no. 14, pp. 5395–5406, 1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].Gungor B., Adiguzel E., Gursel I., Yilmaz B., and Gursel M., “Intestinal microbiota in patients with spinal cord injury,” PloS one, vol. 11, no. 1, p. e0145878, 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24].Kigerl K. A., Hall J. C., Wang L., Mo X., Yu Z., and Popovich P. G., “Gut dysbiosis impairs recovery after spinal cord injury,” Journal of Experimental Medicine, vol. 213, no. 12, pp. 2603–2620, 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [25].Kigerl K. A., Mostacada K., and Popovich P. G., “Gut microbiota are disease-modifying factors after traumatic spinal cord injury,” Neurotherapeutics, vol. 15, no. 1, pp. 60–67, 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [26].Zhang C. et al. , “Gut microbiota dysbiosis in male patients with chronic traumatic complete spinal cord injury,” Journal of translational medicine, vol. 16, no. 1, pp. 1–16, 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [27].Battistuzzo C. R., Callister R. J., Callister R., and Galea M. P., “A systematic review of exercise training to promote locomotor recovery in animal models of spinal cord injury,” Journal of neurotrauma, vol. 29, no. 8, pp. 1600–1613, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Chariker J. H. et al. , “Activity/exercise-induced changes in the liver transcriptome after chronic spinal cord injury,” Scientific data, vol. 6, no. 1, pp. 1–9, 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [29].Dupont-Versteegden E. E. et al. , “Exercise-induced gene expression in soleus muscle is dependent on time after spinal cord injury in rats,” Muscle & Nerve: Official Journal of the American Association of Electrodiagnostic Medicine, vol. 29, no. 1, pp. 73–81, 2004. [DOI] [PubMed] [Google Scholar]
  • [30].Engesser-Cesar C., Anderson A. J., Basso D. M., Edgerton V., and Cotman C. W., “Voluntary wheel running improves recovery from a moderate spinal cord injury,” Journal of neurotrauma, vol. 22, no. 1, pp. 157–171, 2005. [DOI] [PubMed] [Google Scholar]
  • [31].Fu J., Wang H., Deng L., and Li J., “Exercise training promotes functional recovery after spinal cord injury,” Neural plasticity, vol. 2016, 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [32].Hutchinson K. J., Gómez-Pinilla F., Crowe M. J., Ying Z., and Basso D. M., “Three exercise paradigms differentially improve sensory recovery after spinal cord contusion in rats,” Brain, vol. 127, no. 6, pp. 1403–1414, 2004. [DOI] [PubMed] [Google Scholar]
  • [33].Sandrow-Feinberg H. R. and Houlé J. D., “Exercise after spinal cord injury as an agent for neuroprotection, regeneration and rehabilitation,” Brain research, vol. 1619, pp. 12–21, 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [34].Smith R. R. et al. , “Swim training initiated acutely after spinal cord injury is ineffective and induces extravasation in and around the epicenter,” Journal of neurotrauma, vol. 26, no. 7, pp. 1017–1027, 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [35].Smith R. R. et al. , “Effects of swimming on functional recovery after incomplete spinal cord injury in rats,” Journal of neurotrauma, vol. 23, no. 6, pp. 908–919, 2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [36].Van Meeteren N. L., Eggers R., Lankhorst A. J., Gispen W. H., and Hamers F. P., “Locomotor recovery after spinal cord contusion injury in rats is improved by spontaneous exercise,” Journal of neurotrauma, vol. 20, no. 10, pp. 1029–1037, 2003. [DOI] [PubMed] [Google Scholar]
  • [37].Anjum A. et al. , “Spinal cord injury: pathophysiology, multimolecular interactions, and underlying recovery mechanisms,” International journal of molecular sciences, vol. 21, no. 20, p. 7533, 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [38].Callahan A. et al. , “Developing a data sharing community for spinal cord injury research,” Experimental neurology, vol. 295, pp. 135–143, 2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [39].Wilkinson M. D. et al. , “The FAIR Guiding Principles for scientific data management and stewardship,” Scientific data, vol. 3, no. 1, pp. 1–9, 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [40].Edgar R., Domrachev M., and Lash A. E., “Gene Expression Omnibus: NCBI gene expression and hybridization array data repository,” Nucleic acids research, vol. 30, no. 1, pp. 207–210, 2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [41].Leinonen R., Sugawara H., Shumway M., and Collaboration I. N. S. D., “The sequence read archive,” Nucleic acids research, vol. 39, no. suppl_1, pp. D19–D21, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [42].Brazma A. et al. , “Minimum information about a microarray experiment (MIAME)—toward standards for microarray data,” Nature genetics, vol. 29, no. 4, pp. 365–371, 2001. [DOI] [PubMed] [Google Scholar]
  • [43].Brazma A. et al. , “ArrayExpress—a public repository for microarray gene expression data at the EBI,” Nucleic acids research, vol. 31, no. 1, pp. 68–71, 2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [44].Mailman M. D. et al. , “The NCBI dbGaP database of genotypes and phenotypes,” Nature genetics, vol. 39, no. 10, pp. 1181–1186, 2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [45].Lemmon V. P. et al. , “Minimum information about a spinal cord injury experiment: a proposed reporting standard for spinal cord injury experiments,” Journal of neurotrauma, vol. 31, no. 15, pp. 1354–1361, 2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [46].Chen K. et al. , “RNA-seq characterization of spinal cord injury transcriptome in acute/subacute phases: a resource for understanding the pathology at the systems level,” PloS one, vol. 8, no. 8, p. e72567, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [47].Weinstein J. N. et al. , “The cancer genome atlas pan-cancer analysis project,” Nature genetics, vol. 45, no. 10, pp. 1113–1120, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [48].Grossman R. L. et al. , “Toward a shared vision for cancer genomic data,” New England Journal of Medicine, vol. 375, no. 12, pp. 1109–1112, 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [49].Lonsdale J. et al. , “The genotype-tissue expression (GTEx) project,” Nature genetics, vol. 45, no. 6, pp. 580–585, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [50].Sayers E. W., O’Sullivan C., and Karsch-Mizrachi I., “Using GenBank and SRA,” in Plant Bioinformatics: Springer, 2022, pp. 1–25. [DOI] [PubMed] [Google Scholar]
  • [51].Andrews S., “FastQC: a quality control tool for high throughput sequence data,” ed: Babraham Bioinformatics, Babraham Institute, Cambridge, United Kingdom, 2010. [Google Scholar]
  • [52].Dobin A. et al. , “STAR: ultrafast universal RNA-seq aligner,” Bioinformatics, vol. 29, no. 1, pp. 15–21, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [53].Liao Y., Smyth G. K., and Shi W., “featureCounts: an efficient general purpose program for assigning sequence reads to genomic features,” Bioinformatics, vol. 30, no. 7, pp. 923–930, 2014. [DOI] [PubMed] [Google Scholar]
  • [54].Wang L., Wang S., and Li W., “RSeQC: quality control of RNA-seq experiments,” Bioinformatics, vol. 28, no. 16, pp. 2184–2185, 2012. [DOI] [PubMed] [Google Scholar]
  • [55].Anders S., Pyl P. T., and Huber W., “HTSeq—a Python framework to work with high-throughput sequencing data,” bioinformatics, vol. 31, no. 2, pp. 166–169, 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [56].Wagner G. P., Kin K., and Lynch V. J., “Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples,” Theory in biosciences, vol. 131, no. 4, pp. 281–285, 2012. [DOI] [PubMed] [Google Scholar]
  • [57].Lawrence M. et al. , “Software for computing and annotating genomic ranges,” PLoS computational biology, vol. 9, no. 8, p. e1003118, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [58].Haas B. J. et al. , “De novo transcript sequence reconstruction from RNA-seq using the Trinity platform for reference generation and analysis,” Nature protocols, vol. 8, no. 8, pp. 1494–1512, 2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [59].Coordinators N. R., “Database resources of the national center for biotechnology information,” Nucleic acids research, vol. 44, no. D1, pp. D7–D19, 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [60].Love M. I., Huber W., and Anders S., “Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2,” Genome biology, vol. 15, no. 12, pp. 1–21, 2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [61].Ashburner M. et al. , “Gene ontology: tool for the unification of biology,” Nature genetics, vol. 25, no. 1, pp. 25–29, 2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [62].Kanehisa M. and Goto S., “KEGG: kyoto encyclopedia of genes and genomes,” Nucleic acids research, vol. 28, no. 1, pp. 27–30, 2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [63].Yu G., Wang L.-G., Han Y., and He Q.-Y., “clusterProfiler: an R package for comparing biological themes among gene clusters,” Omics: a journal of integrative biology, vol. 16, no. 5, pp. 284–287, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [64].Di Giovanni S., Knoblach S. M., Brandoli C., Aden S. A., Hoffman E. P., and Faden A. I., “Gene profiling in spinal cord injury shows role of cell cycle in neuronal death,” Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society, vol. 53, no. 4, pp. 454–468, 2003. [DOI] [PubMed] [Google Scholar]
  • [65].Befort K., Karchewski L., Lanoue C., and Woolf C. J., “Selective up-regulation of the growth arrest DNA damage-inducible gene Gadd45 alpha in sensory and motor neurons after peripheral nerve injury,” European Journal of Neuroscience, vol. 18, no. 4, pp. 911–922, 2003. [DOI] [PubMed] [Google Scholar]
  • [66].Blesch A. et al. , “Conditioning lesions before or after spinal cord injury recruit broad genetic mechanisms that sustain axonal regeneration: superiority to camp-mediated effects,” Experimental neurology, vol. 235, no. 1, pp. 162–173, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [67].Lin C. R. et al. , “GADD45A protects against cell death in dorsal root ganglion neurons following peripheral nerve injury,” Journal of neuroscience research, vol. 89, no. 5, pp. 689–699, 2011. [DOI] [PubMed] [Google Scholar]
  • [68].Holmes F. E., Kerr N., Chen Y.-J., Vanderplank P., McArdle C. A., and Wynick D., “Targeted disruption of the orphan receptor Gpr151 does not alter pain-related behaviour despite a strong induction in dorsal root ganglion expression in a model of neuropathic pain,” Molecular and Cellular Neuroscience, vol. 78, pp. 35–40, 2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [69].Lee B. et al. , “Promoting axon regeneration by enhancing the non-coding function of the injury-responsive coding gene Gpr151,” bioRxiv, 2021. [Google Scholar]
  • [70].Robinson M. et al. , “FLRT3 is expressed in sensory neurons after peripheral nerve injury and regulates neurite outgrowth,” Molecular and Cellular Neuroscience, vol. 27, no. 2, pp. 202–214, 2004. [DOI] [PubMed] [Google Scholar]
  • [71].Tanabe K., Bonilla I., Winkles J. A., and Strittmatter S. M., “Fibroblast growth factor-inducible-14 is induced in axotomized neurons and promotes neurite outgrowth,” Journal of Neuroscience, vol. 23, no. 29, pp. 9675–9686, 2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [72].Tsuji L. et al. , “FLRT3, a cell surface molecule containing LRR repeats and a FNIII domain, promotes neurite outgrowth,” Biochemical and biophysical research communications, vol. 313, no. 4, pp. 1086–1091, 2004. [DOI] [PubMed] [Google Scholar]
  • [73].Crisponi L., Buers I., and Rutsch F., “CRLF1 and CLCF1 in Development, Health and Disease,” International journal of molecular sciences, vol. 23, no. 2, p. 992, 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [74].Hobson S. et al. , “Galanin acts as a trophic factor to the central and peripheral nervous systems,” Cellular and molecular life sciences: CMLS, vol. 65, no. 12, pp. 1806–1812, 2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [75].Wynick D., Thompson S. W., and McMahon S. B., “The role of galanin as a multi-functional neuropeptide in the nervous system,” Current opinion in pharmacology, vol. 1, no. 1, pp. 73–77, 2001. [DOI] [PubMed] [Google Scholar]
  • [76].Jiang B.-C. et al. , “Demethylation of G-protein-coupled receptor 151 promoter facilitates the binding of Krüppel-like factor 5 and enhances neuropathic pain after nerve injury in mice,” Journal of Neuroscience, vol. 38, no. 49, pp. 10535–10551, 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [77].Xia L.-P. et al. , “GPR151 in nociceptors modulates neuropathic pain via regulating P2X3 function and microglial activation,” Brain, vol. 144, no. 11, pp. 3405–3420, 2021. [DOI] [PubMed] [Google Scholar]
  • [78].Gaudet P., Livstone M. S., Lewis S. E., and Thomas P. D., “Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium,” Briefings in bioinformatics, vol. 12, no. 5, pp. 449–462, 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [79].Kumamaru H. et al. , “Generation and post-injury integration of human spinal cord neural stem cells,” Nature methods, vol. 15, no. 9, pp. 723–731, 2018. [DOI] [PubMed] [Google Scholar]
  • [80].Pereira I. M., Marote A., Salgado A. J., and Silva N. A., “Filling the gap: neural stem cells as a promising therapy for spinal cord injury,” Pharmaceuticals, vol. 12, no. 2, p. 65, 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [81].White N. and Sakiyama-Elbert S. E., “Derivation of specific neural populations from pluripotent cells for understanding and treatment of spinal cord injury,” Developmental Dynamics, vol. 248, no. 1, pp. 78–87, 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [82].Yu C. et al. , “The application of neural stem/progenitor cells for regenerative therapy of spinal cord injury,” Current stem cell research & therapy, vol. 14, no. 6, pp. 495–503, 2019. [DOI] [PubMed] [Google Scholar]
  • [83].García-Caballero A. et al. , “The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3. 2 channel activity,” Neuron, vol. 83, no. 5, pp. 1144–1158, 2014. [DOI] [PubMed] [Google Scholar]
  • [84].Veldman M. B., Bemben M. A., and Goldman D., “Tuba1a gene expression is regulated by KLF6/7 and is necessary for CNS development and regeneration in zebrafish,” Molecular and Cellular Neuroscience, vol. 43, no. 4, pp. 370–383, 2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [85].Fu H., Zhao Y., Hu D., Wang S., Yu T., and Zhang L., “Depletion of microglia exacerbates injury and impairs function recovery after spinal cord injury in mice,” Cell death & disease, vol. 11, no. 7, pp. 1–12, 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [86].Gerber Y. N. et al. , “CSF1R inhibition reduces microglia proliferation, promotes tissue preservation and improves motor recovery after spinal cord injury,” Frontiers in cellular neuroscience, vol. 12, p. 368, 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [87].Okada S. et al. , “Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury,” Nature medicine, vol. 12, no. 7, pp. 829–834, 2006. [DOI] [PubMed] [Google Scholar]
  • [88].Noble B. T., Brennan F. H., and Popovich P. G., “The spleen as a neuroimmune interface after spinal cord injury,” Journal of Neuroimmunology, vol. 321, pp. 1–11, 2018. [DOI] [PubMed] [Google Scholar]
  • [89].Huang J. J., Ma W. J., and Yokoyama S., “Expression and immunolocalization of Gpnmb, a glioma-associated glycoprotein, in normal and inflamed central nervous systems of adult rats,” Brain and behavior, vol. 2, no. 2, pp. 85–96, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [90].Cavone L. et al. , “A unique macrophage subpopulation signals directly to progenitor cells to promote regenerative neurogenesis in the zebrafish spinal cord,” Developmental cell, vol. 56, no. 11, pp. 1617–1630. e6, 2021. [DOI] [PubMed] [Google Scholar]
  • [91].Goldshmit Y. et al. , “Blockage of lysophosphatidic acid signaling improves spinal cord injury outcomes,” The American journal of pathology, vol. 181, no. 3, pp. 978–992, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [92].Jaerve A. and Müller H. W., “Chemokines in CNS injury and repair,” Cell and tissue research, vol. 349, no. 1, pp. 229–248, 2012. [DOI] [PubMed] [Google Scholar]
  • [93].Faden A. I., Wu J., Stoica B. A., and Loane D. J., “Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury,” British journal of pharmacology, vol. 173, no. 4, pp. 681–691, 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [94].Chen G., Fang X., and Yu M., “Regulation of gene expression in rats with spinal cord injury based on microarray data,” Molecular medicine reports, vol. 12, no. 2, pp. 2465–2472, 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [95].Zhang J. et al. , “Astrocytic YAP prevents the demyelination through promoting expression of cholesterol synthesis genes in experimental autoimmune encephalomyelitis,” Cell death & disease, vol. 12, no. 10, pp. 1–11, 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [96].Van Steenwinckel J. et al. , “CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury,” Journal of Neuroscience, vol. 31, no. 15, pp. 5865–5875, 2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [97].Xu X. et al. , “Bone Marrow Stromal Cell Antigen 2: Is a Potential Neuroinflammation Biomarker of SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis in Pre-symptomatic Stage,” Frontiers in Neuroscience, vol. 15, 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [98].Wahane S. et al. , “Diversified transcriptional responses of myeloid and glial cells in spinal cord injury shaped by HDAC3 activity,” Science Advances, vol. 7, no. 9, p. eabd8811, 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [99].Kobayashi M., Konishi H., Sayo A., Takai T., and Kiyama H., “TREM2/DAP12 signal elicits proinflammatory response in microglia and exacerbates neuropathic pain,” Journal of Neuroscience, vol. 36, no. 43, pp. 11138–11150, 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [100].Gaudet A. D. et al. , “Spinal cord injury in rats dysregulates diurnal rhythms of fecal output and liver metabolic indicators,” Journal of Neurotrauma, vol. 36, no. 12, pp. 1923–1934, 2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [101].Dhar S. S. et al. , “MLL4 is required to maintain broad H3K4me3 peaks and super-enhancers at tumor suppressor genes,” Molecular cell, vol. 70, no. 5, pp. 825–841. e6, 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [102].Dickendesher T. L. et al. , “NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans,” Nature neuroscience, vol. 15, no. 5, pp. 703–712, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [103].Brockie S., Hong J., and Fehlings M. G., “The role of microglia in modulating neuroinflammation after spinal cord injury,” International Journal of Molecular Sciences, vol. 22, no. 18, p. 9706, 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [104].Cordaro M., Casili G., Paterniti I., Cuzzocrea S., and Esposito E., “Fumaric acid esters attenuate secondary degeneration after spinal cord injury,” Journal of neurotrauma, vol. 34, no. 21, pp. 3027–3040, 2017. [DOI] [PubMed] [Google Scholar]
  • [105].Abe N. and Cavalli V., “Nerve injury signaling,” Current opinion in neurobiology, vol. 18, no. 3, pp. 276–283, 2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [106].Bastien D. and Lacroix S., “Cytokine pathways regulating glial and leukocyte function after spinal cord and peripheral nerve injury,” Experimental neurology, vol. 258, pp. 62–77, 2014. [DOI] [PubMed] [Google Scholar]
  • [107].Genovese T. et al. , “Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury,” Journal of Pharmacology and Experimental Therapeutics, vol. 326, no. 1, pp. 12–23, 2008. [DOI] [PubMed] [Google Scholar]
  • [108].Keane R. W., Davis A. R., and Dietrich W. D., “Inflammatory and apoptotic signaling after spinal cord injury,” Journal of neurotrauma, vol. 23, no. 3–4, pp. 335–344, 2006. [DOI] [PubMed] [Google Scholar]
  • [109].Yu C.-G. and Yezierski R. P., “Activation of the ERK1/2 signaling cascade by excitotoxic spinal cord injury,” Molecular brain research, vol. 138, no. 2, pp. 244–255, 2005. [DOI] [PubMed] [Google Scholar]
  • [110].Avraham O., Feng R., Ewan E. E., Rustenhoven J., Zhao G., and Cavalli V., “Profiling sensory neuron microenvironment after peripheral and central axon injury reveals key pathways for neural repair,” Elife, vol. 10, p. e68457, 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [111].Floriddia E. M. et al. , “Distinct oligodendrocyte populations have spatial preference and different responses to spinal cord injury,” Nature communications, vol. 11, no. 1, pp. 1–15, 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [112].Hou J. et al. , “Heterogeneity analysis of astrocytes following spinal cord injury at single-cell resolution,” The FASEB Journal, vol. 36, no. 8, p. e22442, 2022. [DOI] [PubMed] [Google Scholar]
  • [113].Li Y. et al. , “Microglia-organized scar-free spinal cord repair in neonatal mice,” Nature, vol. 587, no. 7835, pp. 613–618, 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [114].Matson K. J. et al. , “Single cell atlas of spinal cord injury in mice reveals a pro-regenerative signature in spinocerebellar neurons,” Nature Communications, vol. 13, no. 1, pp. 1–16, 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [115].Squair J. W. et al. , “Confronting false discoveries in single-cell differential expression,” Nature communications, vol. 12, no. 1, pp. 1–15, 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [116].Wang J. et al. , “Single-cell transcriptome analysis reveals the immune heterogeneity and the repopulation of microglia by Hif1α in mice after spinal cord injury,” Cell death & disease, vol. 13, no. 5, pp. 1–12, 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement 1
media-1.pdf (2.7MB, pdf)
Supplement 2
media-2.pdf (456.2KB, pdf)

Data Availability Statement

The SQLite database, flat files used to construct the database, and the web interface can be accessed at: http://162.215.210.70/~tracks/SCI-GEE/ .


Articles from bioRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES